Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
Clinical trial NCT00040885 · COMPLETED
Trial details
- NCT number
- NCT00040885
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Primary completion
- 2006-02-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.